These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 18544705)

  • 1. Carcinoembryonic antigen-related cell adhesion molecule 1: a link between insulin and lipid metabolism.
    DeAngelis AM; Heinrich G; Dai T; Bowman TA; Patel PR; Lee SJ; Hong EG; Jung DY; Assmann A; Kulkarni RN; Kim JK; Najjar SM
    Diabetes; 2008 Sep; 57(9):2296-303. PubMed ID: 18544705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver-specific reconstitution of CEACAM1 reverses the metabolic abnormalities caused by its global deletion in male mice.
    Russo L; Muturi HT; Ghadieh HE; Ghanem SS; Bowman TA; Noh HL; Dagdeviren S; Dogbey GY; Kim JK; Heinrich G; Najjar SM
    Diabetologia; 2017 Dec; 60(12):2463-2474. PubMed ID: 28913658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver-specific rescuing of CEACAM1 reverses endothelial and cardiovascular abnormalities in male mice with null deletion of Ceacam1 gene.
    Russo L; Muturi HT; Ghadieh HE; Wisniewski AM; Morgan EE; Quadri SS; Landesberg GP; Siragy HM; Vazquez G; Scalia R; Gupta R; Najjar SM
    Mol Metab; 2018 Mar; 9():98-113. PubMed ID: 29396368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperinsulinemia drives hepatic insulin resistance in male mice with liver-specific Ceacam1 deletion independently of lipolysis.
    Ghadieh HE; Russo L; Muturi HT; Ghanem SS; Manaserh IH; Noh HL; Suk S; Kim JK; Hill JW; Najjar SM
    Metabolism; 2019 Apr; 93():33-43. PubMed ID: 30664851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of glucose intolerance in mice with dominant negative mutation of CEACAM1.
    Park SY; Cho YR; Kim HJ; Hong EG; Higashimori T; Lee SJ; Goldberg IJ; Shulman GI; Najjar SM; Kim JK
    Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E517-24. PubMed ID: 16638824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased osteoclastogenesis and high bone mass in mice with impaired insulin clearance due to liver-specific inactivation to CEACAM1.
    Huang S; Kaw M; Harris MT; Ebraheim N; McInerney MF; Najjar SM; Lecka-Czernik B
    Bone; 2010 Apr; 46(4):1138-45. PubMed ID: 20044046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leptin Resistance Contributes to Obesity in Mice with Null Mutation of Carcinoembryonic Antigen-related Cell Adhesion Molecule 1.
    Heinrich G; Russo L; Castaneda TR; Pfeiffer V; Ghadieh HE; Ghanem SS; Wu J; Faulkner LD; Ergün S; McInerney MF; Hill JW; Najjar SM
    J Biol Chem; 2016 May; 291(21):11124-32. PubMed ID: 27002145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of hepatic fibrosis by carcinoembryonic antigen-related cell adhesion molecule 1.
    Helal RA; Russo L; Ghadieh HE; Muturi HT; Asalla S; Lee AD; Gatto-Weis C; Najjar SM
    Metabolism; 2021 Aug; 121():154801. PubMed ID: 34058224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted disruption of carcinoembryonic antigen-related cell adhesion molecule 1 promotes diet-induced hepatic steatosis and insulin resistance.
    Xu E; Dubois MJ; Leung N; Charbonneau A; Turbide C; Avramoglu RK; DeMarte L; Elchebly M; Streichert T; Lévy E; Beauchemin N; Marette A
    Endocrinology; 2009 Aug; 150(8):3503-12. PubMed ID: 19406938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of CEACAM1 in hepatocytes causes hepatic fibrosis.
    Zaidi S; Asalla S; Muturi HT; Russo L; Abdolahipour R; Belew GD; Iglesias MB; Feraudo M; Leon L; Kuo E; Liu X; Kumarasamy S; Ghadieh HE; Gatto-Weis C; Zarrinpar A; Duarte S; Najjar SM
    Eur J Clin Invest; 2024 Jul; 54(7):e14177. PubMed ID: 38381498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ceacam1 deletion causes vascular alterations in large vessels.
    Najjar SM; Ledford KJ; Abdallah SL; Paus A; Russo L; Kaw MK; Ramakrishnan SK; Muturi HT; Raphael CK; Lester SG; Heinrich G; Pierre SV; Benndorf R; Kleff V; Jaffa AA; Lévy E; Vazquez G; Goldberg IJ; Beauchemin N; Scalia R; Ergün S
    Am J Physiol Endocrinol Metab; 2013 Aug; 305(4):E519-29. PubMed ID: 23800882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin Sensitivity Is Retained in Mice with Endothelial Loss of Carcinoembryonic Antigen Cell Adhesion Molecule 1.
    Muturi HT; Khuder SS; Ghadieh HE; Esakov EL; Noh H; Kang H; McInerney MF; Kim JK; Lee AD; Najjar SM
    Cells; 2021 Aug; 10(8):. PubMed ID: 34440862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carcinoembryonic antigen-related cell adhesion molecule 2 controls energy balance and peripheral insulin action in mice.
    Heinrich G; Ghosh S; Deangelis AM; Schroeder-Gloeckler JM; Patel PR; Castaneda TR; Jeffers S; Lee AD; Jung DY; Zhang Z; Opland DM; Myers MG; Kim JK; Najjar SM
    Gastroenterology; 2010 Aug; 139(2):644-52, 652.e1. PubMed ID: 20381490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of nonalcoholic steatohepatitis in insulin-resistant liver-specific S503A carcinoembryonic antigen-related cell adhesion molecule 1 mutant mice.
    Lee SJ; Heinrich G; Fedorova L; Al-Share QY; Ledford KJ; Fernstrom MA; McInerney MF; Erickson SK; Gatto-Weis C; Najjar SM
    Gastroenterology; 2008 Dec; 135(6):2084-95. PubMed ID: 18848945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fenofibrate Decreases Insulin Clearance and Insulin Secretion to Maintain Insulin Sensitivity.
    Ramakrishnan SK; Russo L; Ghanem SS; Patel PR; Oyarce AM; Heinrich G; Najjar SM
    J Biol Chem; 2016 Nov; 291(46):23915-23924. PubMed ID: 27662905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction between altered insulin and lipid metabolism in CEACAM1-inactive transgenic mice.
    Dai T; Abou-Rjaily GA; Al-Share' QY; Yang Y; Fernström MA; Deangelis AM; Lee AD; Sweetman L; Amato A; Pasquali M; Lopaschuk GD; Erickson SK; Najjar SM
    J Biol Chem; 2004 Oct; 279(43):45155-61. PubMed ID: 15316023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin acutely decreases hepatic fatty acid synthase activity.
    Najjar SM; Yang Y; Fernström MA; Lee SJ; Deangelis AM; Rjaily GA; Al-Share QY; Dai T; Miller TA; Ratnam S; Ruch RJ; Smith S; Lin SH; Beauchemin N; Oyarce AM
    Cell Metab; 2005 Jul; 2(1):43-53. PubMed ID: 16054098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-fat diet amplifies renal renin angiotensin system expression, blood pressure elevation, and renal dysfunction caused by Ceacam1 null deletion.
    Li C; Culver SA; Quadri S; Ledford KL; Al-Share QY; Ghadieh HE; Najjar SM; Siragy HM
    Am J Physiol Endocrinol Metab; 2015 Nov; 309(9):E802-10. PubMed ID: 26374765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CEACAM1 regulates insulin clearance in liver.
    Poy MN; Yang Y; Rezaei K; Fernström MA; Lee AD; Kido Y; Erickson SK; Najjar SM
    Nat Genet; 2002 Mar; 30(3):270-6. PubMed ID: 11850617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of CEACAM1 in endothelial cells causes hepatic fibrosis.
    Muturi HT; Ghadieh HE; Abdolahipour R; Stankus HL; Belew GD; Liu JK; Jahromi MS; Lee AD; Singer BB; Angeli-Pahim I; Sehrawat TS; Malhi H; Verhulst S; van Grunsven LA; Zarrinpar A; Duarte S; Najjar SM
    Metabolism; 2023 Jul; 144():155562. PubMed ID: 37088122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.